Company Filing History:
3 out of 27 
2 out of 3 
1 out of 1 Years Active: 2013-2019
Title: The Innovative Contributions of Harald Debelak
Introduction
Harald Debelak is a notable inventor based in Hilden, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotide analogs. With a total of six patents to his name, Debelak's work has had a considerable impact on immunology and pharmaceutical applications.
Latest Patents
One of Debelak's latest patents focuses on CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity. This invention relates to oligonucleotides that include at least one lipophilic substituted nucleotide analog and a pyrimidine-purine dinucleotide. Additionally, the invention encompasses pharmaceutical compositions and methods of use thereof, showcasing the potential for therapeutic applications.
Career Highlights
Throughout his career, Debelak has worked with prominent companies in the pharmaceutical sector, including Coley Pharmaceutical GmbH and Adiutide Pharmaceuticals GmbH. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in immunostimulatory therapies.
Collaborations
Debelak has collaborated with several professionals in his field, including Eugen Uhlmann and Marion Jurk. These partnerships have facilitated the exchange of ideas and fostered innovation in the development of new therapeutic solutions.
Conclusion
Harald Debelak's contributions to biotechnology and immunology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the development of novel pharmaceutical therapies.